Valuation : Burning Rock Biotech Limited

Market Cap 649M 96.51M 83.04M 77.93M 71.3M 133M 9.12B 134M 922M 359M 4.66B 362M 355M 15.02B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 211M 31.38M 27M 25.34M 23.18M 43.27M 2.97B 43.61M 300M 117M 1.52B 118M 115M 4.88B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+8.74%
1 week-0.50%
Current month+5.29%
1 month+12.56%
3 months+14.50%
6 months-57.73%
Current year-50.62%
1 week 9.15
Extreme 9.15
10.42
1 month 8.81
Extreme 8.81
11.27
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
213.65
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 2013-12-31
Chief Executive Officer 48 2013-12-31
Director of Finance/CFO - 2024-09-26
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 2014-05-31
Director/Board Member 63 2016-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/31/26 Buy

Chief Executive Officer

314,870 0.3584%
3/18/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
3/17/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
+8.74%-0.50%+25.16%-21.65% 96.5M
-0.22%-4.17%+93.74%+446.16% 46.87B
+0.44%-1.03%+21.63%+62.91% 26.9B
+3.04%-3.79%-18.74%-40.06% 6.64B
-2.34%-1.89%+4.21%+137.43% 5.96B
+0.47%-0.58%+15.36%+77.39% 3.39B
-0.39%-3.23%-32.12%+1,876.20% 2.59B
+0.55%-5.98%+113.98%+23.50% 2.24B
+6.53%+6.24%+29.29%+34.89% 2.09B
-2.60%-5.64%-13.69%-55.31% 1.83B
Average +1.43%-2.74%+23.88%+254.14% 9.86B
Weighted average by Cap. +0.21%-3.23%+52.12%+286.95%

Financials

2024 2025
Net sales 516M 76.76M 66.05M 61.98M 56.71M 106M 7.26B 107M 733M 286M 3.71B 288M 282M 11.94B 540M 80.3M 69.09M 64.83M 59.32M 111M 7.59B 112M 767M 299M 3.88B 302M 295M 12.49B
Net income -347M -51.58M -44.38M -41.65M -38.11M -71.12M -4.88B -71.69M -493M -192M -2.49B -194M -189M -8.03B -55.35M -8.24M -7.09M -6.65M -6.08M -11.36M -779M -11.45M -78.67M -30.64M -398M -30.93M -30.26M -1.28B
Net Debt -474M -70.49M -60.65M -56.91M -52.07M -97.19M -6.66B -97.96M -673M -262M -3.41B -265M -259M -10.97B -438M -65.13M -56.04M -52.59M -48.12M -89.8M -6.16B -90.52M -622M -242M -3.15B -245M -239M -10.13B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
26-09-03 $9.950 +8.74% 127,535
26-09-02 $9.150 -0.76% 3,621
26-09-01 $9.220 -2.43% 3,403
26-08-31 $9.450 -7.26% 5,704
26-08-28 $10.19 +1.90% 29,177